D-0730-2026 Class II Ongoing
FDA drug recall D-0730-2026 was initiated by MICRO LABS USA INC on Jul 22, 2026 and is designated Class II. Reason for recall: Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops. The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 5, 2026
- Initiation Date
- Jul 22, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manufactured by: Micro Labs Limited, India, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873. NDC 42571-147-26.
Reason for recall
Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
Distribution pattern
Nationwide in the USA.
Code information
Lot # DLHU0031, Exp Date: 06/30/2027.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0730-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026